Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01369
|
|||||
Drug Name |
Prostaglandin A2
|
|||||
Synonyms |
medullin; PGA2
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Human immunodeficiency virus infection [ICD11: 1C62.Z] | Phase 1 | [1] | |||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C20H30O4
|
|||||
Canonical SMILES |
CCCCCC(C=CC1C=CC(=O)C1CC=CCCCC(=O)O)O
|
|||||
InChI |
InChI=1S/C20H30O4/c1-2-3-6-9-17(21)14-12-16-13-15-19(22)18(16)10-7-4-5-8-11-20(23)24/h4,7,12-18,21H,2-3,5-6,8-11H2,1H3,(H,23,24)/b7-4-,14-12+/t16-,17-,18+/m0/s1
|
|||||
InChIKey |
MYHXHCUNDDAEOZ-FOSBLDSVSA-N
|
|||||
CAS Number |
CAS 13345-50-1
|
|||||
Pharmaceutical Properties | Molecular Weight | 334.4 | Topological Polar Surface Area | 74.6 | ||
Heavy Atom Count | 24 | Rotatable Bond Count | 12 | |||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 4 | |||
XLogP |
3.6
|
|||||
PubChem CID | ||||||
PubChem SID |
8237
, 599108
, 855670
, 4265975
, 8616420
, 14717647
, 14924515
, 24898548
, 26522686
, 26751479
, 26751480
, 39289869
, 47216545
, 47216546
, 50026811
, 50103989
, 53788336
, 57357905
, 79622497
, 85787701
, 92298423
, 92309876
, 99300790
, 99302308
, 103756910
, 104046431
, 113854152
, 135056758
, 137007967
, 139340658
, 162225876
, 164814196
, 178102899
, 179205555
, 198943825
, 228253856
, 250136889
, 252356257
, 252455600
, 252457317
, 252469022
|
|||||
ChEBI ID |
CHEBI:27820
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
References | ||||||
1 | ClinicalTrials.gov (NCT00301184) Safety of and Immune Response to a DNA HIV Vaccine (pGA2/JS7) Boosted With a Modified Vaccinia HIV Vaccine (MVA/HIV62) in Healthy Adults | |||||
2 | Unveiling the role of multidrug resistance proteins in hypertension. Hypertension. 2009 Aug;54(2):210-6. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.